Abstract
The pleural space, which normally contains approximately 10 mL of fluid on either side, can be a host to a variety of pathologic conditions. The most common process to affect this space is increased fluid volume, known as a pleural effusion. An effusion may have a variety of causes, and both imaging and laboratory evaluation are used to distinguish among these etiologies. Other collections in the pleural space include chylothorax, hemothorax, or pneumothorax, and these are also important to consider on radiologic and clinical workup. Primary pleural malignancies, while rare, can be life threatening, and imaging can play a large part in the diagnosis and management of these entities. The most common malignancy in the pleural space is metastatic disease. The most common primary pleural malignancy is mesothelioma, a deadly neoplasm that is most often associated with asbestos exposure. Other pleural neoplasms, including solitary fibrous tumor of the pleura, are even rarer. This chapter highlights the key concepts of pleural disease, illustrates radiologic examples of these conditions, and provides a background into each disease process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Light RW, MacGregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507–513.
Dweik R. Pleural disease. Cleveland clinic center for continuing education. 2011. Web. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/pulmonary/pleural-disease. Accessed 23 June 2011.
Waite RJ, Carbonneau RJ, Balikian JP, et al. Parietal pleural changes in empyema: appearances at CT. Radiology. 1990;175:145–150.
Rosado-de-Christenson ML, et al. From the archives of the AFIP. Localized fibrous tumors of the pleura. RadioGraphics. 2003;23:759–783.
Roth BJ, O’Meara TF, Cragun WH. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest. 1990;98:546–549.
Strzalka C, Yost M. Treatment of fibrothorax using intrapleural tissue plasminogen activator. Hosp Physician. Nov. 2002;65–67.
Ghoshal AG. Fibrothorax: problem, profile, and prevention. J Indian Med Assoc. 1997;95(12):610–612.
Pistoli M, Rusthoven J. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Chest. 2004;126 (4):1318–1329.
Montjoy C, et al. Mesothelioma review. West Va Med J. 2009;105(3):13–16.
Helm EJ, et al. Imaging of the pleura. J Magn Reson Imaging. 2010;32:1275–1286.
Ismail-Khan R, et al. Malignant pleural mesothelioma: a comprehensive review. Cancer Control. 2006;13(4):255–263.
Benamore RE, et al. Use of imaging in the management of malignant pleural mesothelioma. Clin Radiol. 2005;60(12):1237–1247.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rastogi, A.K., Kanne, J.P. (2012). Pleural Disease. In: Kanne, J. (eds) Clinically Oriented Pulmonary Imaging. Respiratory Medicine. Humana Press. https://doi.org/10.1007/978-1-61779-542-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-61779-542-8_6
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-541-1
Online ISBN: 978-1-61779-542-8
eBook Packages: MedicineMedicine (R0)